Pyrotinib versus trastuzumab emtansine for HER2-positive metastatic breast cancer after previous trastuzumab and lapatinib treatment: a real-world study
@article{ATM59062, author = {Feng Li and Fengrui Xu and Jianbin Li and Tao Wang and Li Bian and Shaohua Zhang and Zefei Jiang}, title = {Pyrotinib versus trastuzumab emtansine for HER2-positive metastatic breast cancer after previous trastuzumab and lapatinib treatment: a real-world study}, journal = {Annals of Translational Medicine}, volume = {9}, number = {2}, year = {2020}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/59062} }